Suramin and radiotherapy in newly diagnosed glioblastoma: Phase 2 NABTT CNS Consortium study

Suramin is a polysulfonated naphthylurea that inhibits the function of growth factors and growth factor receptors implicated in glioma progression, angiogenesis, and radioresistance. The safety and benefits of combining inhibitors of angiogenesis and growth factors with cytotoxic therapies in patien...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Laterra, John J., Grossman, Stuart A., Carson, Kathryn A., Lesser, Glenn J., Hochberg, Fred H., Gilbert, Mark R.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Duke University Press 2004
Konular:
Clinical Investigations
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC1871972/
https://ncbi.nlm.nih.gov/pubmed/14769135
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1215/S1152851703000127
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller